These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10647291)

  • 1. [Progress and new perspective treatments of systemic fungal infections].
    Wierzbicka M
    Pneumonol Alergol Pol; 1999; 67(7-8):375-80. PubMed ID: 10647291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 3. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive fungal infections.
    Warnock DW
    Hosp Med; 1998 Apr; 59(4):266-7. PubMed ID: 9722362
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifungal treatment in patients with cancer.
    Viscoli C; Castagnola E; Machetti M
    J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
    Watanabe K
    Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2257-62. PubMed ID: 9921211
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focusing on therapy of systemic mycoses].
    Internist (Berl); 1995 Dec; 36(12 Suppl):1-12. PubMed ID: 9022383
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal infection overview.
    Treat Rev; 1995 May; (no 18):10. PubMed ID: 11362589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.